Skip to main content
. 2022 May 3;6(5):e37348. doi: 10.2196/37348

Table 3.

Differences in self-reported physical activity and sedentary behavior at baseline (T0), 4 weeks (T1), and 8 weeks (T2) according to history of activity tracker use (N=87).

Variable Friedman test T0, mean (SD) T1, mean (SD) T2, mean (SD) P value within-subject effect (time)a

χ2 (df=2) P value


T0 vs T1 T0 vs T2
Prior use of activity tracker (n=40)

Walking (min/week) 6.993 .03 186.00 (238.22) 168.50 (145.51) 208.75 (185.72) .38 .07

MPAb (min/week) 1.476 .48 62.5 (95.48) 67.25 (92.68) 76.50 (110.70)

VPAc (min/week) 1.317 .52 69.00 (77.65) 72.5 (80.69) 78.5 (78.92)

Total PAd (METe min/week) 4.088 .13 1398.80 (1269.45) 1384.05 (1165.64) 1614.88 (1369.12)

Days of MVPAf≥30 min/day 0.774 .68 2.70 (1.94) 3.25 (1.86) 3.37 (2.03)

Sitting (min/day) 11.036 .004 365.50 (203.61) 285.00 (182.01) 292.50 (192.80) .002 .04

Screen time (min/day) 3.263 .20 195.25 (173.31) 154.25 (108.96) 162.25 (168.96)
Never used activity tracker (n=47)

Walking (min/week) 3.012 .22 175.53 (284.74) 167.23 (165.03) 292.13 (391.49)

MPA (min/week) 4.114 .13 59.79 (79.63) 60.85 (102.42) 103.19 (190.47)

VPA (min/week) 0.013 .99 57.45 (70.42) 58.72 (84.20) 70.64 (134.28)

Total PA (MET min/week) 0.973 .62 1287.34 (1411.50) 1273.57 (1277.72) 2072.11 (2637.84)

Days of MVPA≥30 min/day 1.244 .54 2.79 (2.03) 3.08 (2.19) 2.98 (1.97)

Sitting (min/day) 4.333 .12 307.66 (198.22) 239.57 (187.16) 245.53 (187.06)

Screen time (min/day) 3.810 .15 159.36 (139.36) 136.60 (153.07) 131.06 (127.66)

aWilcoxon signed-rank tests with P<.025 (planned comparisons T0 vs T1 and T0 vs T1) considered statistically significant. The Wilcoxon signed-rank test was only undertaken when the Friedman test was significant (P<.05).

bMPA: moderate-intensity physical activity.

cVPA: vigorous-intensity physical activity.

dPA: physical activity.

eMET: metabolic equivalent.

fMVPA: moderate-to-vigorous physical activity.